Emily Williams has been appointed to serve as Cleveland Clinic’s chief compliance officer, effective Sept. 1.
Category: Static
Babylon Health files for bankruptcy
London-based digital-first healthcare platform Babylon Health has filed for Chapter 7 bankruptcy for two subsidiaries — Babylon Healthcare and Babylon Inc. — as it shuts down core U.S. operations, according to documents filed Aug. 9 in a Delaware bankr…
Oklahoma health system CEO criticizes Leapfrog rankings
Hospital rankings, particularly those from U.S. News & World Report, have drawn scrutiny from health system leaders in recent months. Now, The Leapfrog Group — known for assigning hospitals letter grades — is also facing criticism.
Why digital transformation raises ethical questions in healthcare
One of the greatest challenges health systems face when it comes to digital transformation is striking a balance between leveraging advanced technology and maintaining patient privacy, data security and ethical considerations, according to Terri Couts,…
JPS hospital bond program likely to go over $1.5B budget
Fort Worth, Texas-based JPS Health Network, a 582-bed system, is likely to go over a $1.5 billion budget for new capital projects, according to an Aug. 18 Fort Worth Star-Telegram report.
JPS hospital bond program likely to go over $1.5B budget
Fort Worth, Texas-based JPS Health Network, a 582-bed system, is likely to go over a $1.5 billion budget for new capital projects, according to an Aug. 18 Fort Worth Star-Telegram report.
NYU Langone using Microsoft's GPT4
In March, New York City-based NYU Langone Health requested access to Microsoft’s private instances of GPT4 and now has one of the first HIPAA-compliant GPT4 ecosystems in healthcare.
In US, GLP-1s cost hundreds more than similar nations
Glucagon-like peptide-1 receptor agonists, which include Ozempic and Mounjaro, cost between five to 10 times more in the U.S. than other wealthy nations, according to research KFF published Aug. 17.
In US, GLP-1s cost hundreds more than similar nations
Glucagon-like peptide-1 receptor agonists, which include Ozempic and Mounjaro, cost between five to 10 times more in the U.S. than other wealthy nations, according to research KFF published Aug. 17.
Hawaii's sole burn unit records highest-ever patient influx
After one of the deadliest wildfires in U.S. history hit Maui in early August, healthcare workers at Hawaii’s only burn unit were tasked with treating its highest-ever patient influx from one incident, according to The New York Times.
